farnesol has been researched along with cytochalasin b in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Doe, M; Hamada, M; Nishio, K; Tanaka, T; Usuki, Y | 1 |
1 other study(ies) available for farnesol and cytochalasin b
Article | Year |
---|---|
Farnesylpyridinium, an analog of isoprenoid farnesol, induces apoptosis but suppresses apoptotic body formation in human promyelocytic leukemia cells.
Topics: Actin Cytoskeleton; Antineoplastic Agents; Apoptosis; Caspase Inhibitors; Cysteine Proteinase Inhibitors; Cytochalasin B; DNA; DNA Fragmentation; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Farnesol; HL-60 Cells; Humans; Inclusion Bodies; Leukemia, Promyelocytic, Acute; Mitochondria; Nucleic Acid Synthesis Inhibitors; Protein Synthesis Inhibitors; Pyridinium Compounds; Sesquiterpenes | 2002 |